News

Published on 4 Apr 2024 on Benzinga via Yahoo Finance

Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars

Article preview image

Thursday, the FDA granted 510(k) clearance to AngioDynamics Inc’s (NASDAQ:ANGO) AlphaVac F1885 System for pulmonary embolism (PE).

The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for PE, which broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.

Read the rest of the article
NASDAQ.ANGO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Spends US$67k Buying More Shares In AngioDynamics

Even if it's not a huge purchase, we think it was good to see that James Clemmer, the CEO, Presid...

Simply Wall St. via Yahoo Finance 10 Apr 2024
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript April 4, 2024 AngioDynamics, I...

Insider Monkey via Yahoo Finance 8 Apr 2024
AngioDynamics CEO buys $67,000 worth of company stock By Investing.com

In a recent transaction, James C. Clemmer, President and CEO of AngioDynamics Inc (NASDAQ:ANGO),...

Investing.com 8 Apr 2024
AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 16 cents for third-quarter fiscal...

Zacks via Yahoo Finance 5 Apr 2024
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment

AngioDynamics, Inc. ANGO recently announced the FDA 510(k) clearance for its AlphaVac F1885 Syste...

Zacks via Yahoo Finance 5 Apr 2024
AngioDynamics: Fiscal Q3 Earnings Snapshot

AngioDynamics: Fiscal Q3 Earnings Snapshot

Washington Post 4 Apr 2024
Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars

Thursday, the FDA granted 510(k) clearance to AngioDynamics Inc’s (NASDAQ:ANGO) AlphaVac F1885 Sy...

Benzinga via Yahoo Finance 4 Apr 2024
AngioDynamics gets FDA clearance for pulmonary embolism treatment device (NASDAQ:ANGO)

AngioDynamics shares surge after FDA approves label expansion for AlphaVac F1885 System, allowing...

Seeking Alpha 4 Apr 2024
AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

Despite strength in the Med Tech business, AngioDynamics (ANGO) registers overall soft performanc...

Zacks 4 Apr 2024
AngioDynamics (ANGO) Settles Patent Litigations With BD

AngioDynamics, Inc. ANGO recently announced that it has entered into a settlement agreement with ...

Zacks via Yahoo Finance 2 Apr 2024

Copyright Statfolio @ 2024

Social Accounts